Mar 23 An exemplary high-tech biomedical enterprise in Southeast Asia

2018-03-31

On 23rd March, Dr. Allen Lai on behalf of ACT Genomics was invited by Dr. LIU Shih-Chung, Vice Chairman of Taiwan External Trade Development Council (forth from the left) to share his experiences and strategy in promoting Taiwan’s cutting edge cancer molecular profiling among major countries in Southeast Asia. Dr. Liu applauded ACT Genomics’ achievement in successfully positioning itself as an exemplary high-tech enterprise for Taiwan’s biomedical companies in their south bound strategy to clinch the emerging market.

Image title